Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 17, 2020 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 20 | |
| Jun 17, 2020 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Jun 17, 2020 | Chief Legal Officer | Other acquisition or disposition | Form 4 | -- | -- | 15,000 | |
| Jun 19, 2020 | Principal Accounting Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 3,366 | $10.04 | 20,501 | |
| Jun 19, 2020 | Principal Accounting Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 3,366 | $15.00 | 17,135 | |
| Jun 19, 2020 | Principal Accounting Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 3,366 | -- | 6,138 | |
| Jun 29, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | $5.13 | 193,204 | |
| Jun 29, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 30,000 | $15.51 | 163,204 | |
| Jun 29, 2020 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 30,000 | -- | 40,621 | |
| Jul 01, 2020 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 20 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.